|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/26 | (2006.01) |
| (11) | Number of the document | 3212667 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15808356.8 |
| Date of filing the European patent application | 2015-10-28 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
| (46) | Date of publication of the claims translation | 2018-12-10 |
| (86) | Number | PCT/EP2015/074986 |
| Date | 2015-10-28 |
| (87) | Number | WO 2016/066688 |
| Date | 2016-05-06 |
| (30) | Number | Date | Country code |
| P1400510 | 2014-10-28 | HU |
| (72) |
LAZAR, Jozsef, HU
OLAJOS, Marcell, HU
JANOS, Varga-Kugler, HU
|
| (73) |
Richter Gedeon Nyrt.,
Gyömroi t 19-21, 1103 Budapest,
HU
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinė anti-TNF-alfa antikūnų kompozicija |
| PHARMACEUTICAL ANTI-TNF-ALPHA ANTIBODY FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2023-09-25 | 9 | 208.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-01-02 |